Daisy Hochberg
Overview
Explore the profile of Daisy Hochberg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
133
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Katsumi Y, Howe I, Eckbo R, Wong B, Quimby M, Hochberg D, et al.
Brain
. 2024 Oct;
PMID: 39412999
Identifying individuals with early-stage Alzheimer's disease (AD) at greater risk of steeper clinical decline would enable better-informed medical, support, and life planning decisions. Despite accumulating evidence on the clinical prognostic...
2.
Touroutoglou A, Katsumi Y, Rezaii N, Paranhos T, Jones A, Hochberg D, et al.
Brain Stimul
. 2024 Oct;
17(6):1213-1215.
PMID: 39389531
No abstract available.
3.
Rezaii N, Hochberg D, Quimby M, Wong B, Brickhouse M, Touroutoglou A, et al.
Brain
. 2024 Jun;
147(9):3070-3082.
PMID: 38912855
Neurodegenerative dementia syndromes, such as primary progressive aphasias (PPA), have traditionally been diagnosed based, in part, on verbal and non-verbal cognitive profiles. Debate continues about whether PPA is best divided...
4.
Robertson C, Rezaii N, Hochberg D, Quimby M, Wolff P, Dickerson B
medRxiv
. 2024 May;
PMID: 38746086
Introduction: Recent success has been achieved in Alzheimer's disease (AD) clinical trials targeting amyloid beta (β), demonstrating a reduction in the rate of cognitive decline. However, testing methods for amyloid-β...
5.
Katsumi Y, Howe I, Eckbo R, Wong B, Quimby M, Hochberg D, et al.
medRxiv
. 2024 May;
PMID: 38699357
Identifying individuals with early stage Alzheimer's disease (AD) at greater risk of steeper clinical decline would allow professionals and loved ones to make better-informed medical, support, and life planning decisions....
6.
Rezaii N, Hochberg D, Quimby M, Wong B, McGinnis S, Dickerson B, et al.
Front Neurosci
. 2024 Feb;
18:1342909.
PMID: 38379764
Introduction: Posterior Cortical Atrophy (PCA) is a syndrome characterized by a progressive decline in higher-order visuospatial processing, leading to symptoms such as space perception deficit, simultanagnosia, and object perception impairment....
7.
Rezaii N, Quimby M, Wong B, Hochberg D, Brickhouse M, Touroutoglou A, et al.
medRxiv
. 2024 Jan;
PMID: 38234853
Neurodegenerative dementia syndromes, such as Primary Progressive Aphasias (PPA), have traditionally been diagnosed based in part on verbal and nonverbal cognitive profiles. Debate continues about whether PPA is best subdivided...
8.
Rezaii N, Hochberg D, Quimby M, Wong B, McGinnis S, Dickerson B, et al.
medRxiv
. 2023 Dec;
PMID: 38045263
Introduction: Posterior Cortical Atrophy (PCA) is a syndrome characterized by a progressive decline in higher-order visuospatial processing, leading to symptoms such as space perception deficit, simultanagnosia, and object perception impairment....
9.
Josephy-Hernandez S, Rezaii N, Jones A, Loyer E, Hochberg D, Quimby M, et al.
Brain Commun
. 2023 Aug;
5(4):fcad202.
PMID: 37539353
Despite the important role of written language in everyday life, abnormalities in functional written communication have been sparsely investigated in primary progressive aphasia. Prior studies have analysed written language separately...
10.
Rezaii N, Michaelov J, Josephy-Hernandez S, Ren B, Hochberg D, Quimby M, et al.
Ann Neurol
. 2023 Jul;
94(4):647-657.
PMID: 37463059
Objective: Nonfluent aphasia is characterized by simplified sentence structures and word-level abnormalities, including reduced use of verbs and function words. The predominant belief about the disease mechanism is that a...